{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:45:30Z","timestamp":1792791930772,"version":"4.5.0"},"reference-count":190,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA 016672"],"award-info":[{"award-number":["P30 CA 016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/17474086.2025.2604532","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T02:20:36Z","timestamp":1765765236000},"page":"249-268","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Current treatments, practical management, and emerging investigational therapies for myelofibrosis"],"prefix":"10.1080","volume":"19","author":[{"given":"Srinivas","family":"Tantravahi","sequence":"first","affiliation":[{"name":"University of Utah Health","place":["Salt Lake City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"El Chaer","sequence":"additional","affiliation":[{"name":"Miami Cancer Institute","place":["Miami, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithviraj","family":"Bose","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-695940"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-170449"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02609.x"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017578"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0736"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017423"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.813500"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1382872"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.01.035"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-328955"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2017.05.012"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.9490"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.151449"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-245837"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0028-x"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2023.2203318"},{"issue":"8","key":"e_1_3_6_21_1","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele J","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Facchetti F, et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005;90(8):1128\u20131132.","journal-title":"Haematologica"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2024.01.009"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03546"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.023"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030270"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312542"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1434"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679571"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.119"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.1925"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090299"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0484"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2025.2461393"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173509"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.9867"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0107-z"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.169"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-240135"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-579136"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-578435"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.76"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1019-9"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006006"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2024000577"},{"key":"e_1_3_6_47_1","unstructured":"Myeloproliferative Neoplasm. NCCN clinical Pratice guidelines in Oncology. Version 2.2025. Accessed November 21."},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.05.018"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.181297"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110556"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110557"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0527-7"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04682-x"},{"issue":"158","key":"e_1_3_6_54_1","article-title":"Impact of ruxolitinib on survival of patients with myelofibrosis in real world\u2014update of ERNEST (European registry for myeloproliferative neoplasms) study","volume":"5","author":"Guglielmelli PGA","year":"2021","unstructured":"Guglielmelli PGA, Ghirardi A, Carobbio A. Impact of ruxolitinib on survival of patients with myelofibrosis in real world\u2014update of ERNEST (European registry for myeloproliferative neoplasms) study. Hemasphere. 2021;5(suppl; abstr S158).","journal-title":"Hemasphere"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1845334"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19812"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35801"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2429"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16462"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13379"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35489"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19186"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.1590"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30088-1"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00212-6"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18207"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5818"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010151"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003314"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.4418"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30237-5"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02036-0"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)01436-8"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000963"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0417-z"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.148"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33541"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-783225"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3194-4"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006889"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70062"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25777"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.6578"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.728777"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.11.009"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-150172"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000970976.05785.80"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01972"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03572-3"},{"key":"e_1_3_6_90_1","first-page":"S223","article-title":"Pelabresib in combination with ruxolitinib for Janus kinase inhibitor-naive patients with myelofibrosis: 72-week follow-up with long-term efficacy outcomes of the phase iii MANIFEST-2 study. 2025 EHA Library","volume":"4159300","author":"Vannucchi ARR","year":"2025","unstructured":"Vannucchi ARR, Chraniuk D, Grosicki S, et al. Pelabresib in combination with ruxolitinib for Janus kinase inhibitor-naive patients with myelofibrosis: 72-week follow-up with long-term efficacy outcomes of the phase iii MANIFEST-2 study. 2025 EHA Library. Vannucchi A. 2025;4159300:S223.","journal-title":"Vannucchi A"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-1005"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2024.100010"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0959"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)01451-4"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-180844"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15730"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5836"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114363"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00116-8"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02188"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-410712"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000970868.28141.7f"},{"issue":"1","key":"e_1_3_6_103_1","first-page":"65","article-title":"KRT-232, a first-in-class, murine double minute 2 inhibitor (MDM2I), for myelofibrosis (MF) relapsed or refractory (R\/R) to janus-associated kinase inhibitor (JAKI) treatment (TX)","volume":"4","author":"Al-Ali H","year":"2020","unstructured":"Al-Ali H, Delgado RG, Lange A, et al. KRT-232, a first-in-class, murine double minute 2 inhibitor (MDM2I), for myelofibrosis (MF) relapsed or refractory (R\/R) to janus-associated kinase inhibitor (JAKI) treatment (TX). Hemasphere. 2020;4(S1):65.","journal-title":"Hemasphere"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-201642"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2986"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01464-2"},{"key":"e_1_3_6_107_1","unstructured":"Rein LE Scandura JM. EHA Library. 2025;4159298:S221."},{"key":"e_1_3_6_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200268"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.157"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000054"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208038"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.07.042"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.319"},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(02)00969-4"},{"issue":"14","key":"e_1_3_6_115_1","first-page":"3931","article-title":"A novel telomerase template antagonist (GRN163) as a potential anticancer agent","volume":"63","author":"Asai A","year":"2003","unstructured":"Asai A, Oshima Y, Yamamoto Y, et al. A novel telomerase template antagonist (GRN163) as a potential anticancer agent. Cancer Res. 2003;63(14):3931\u20133939.","journal-title":"Cancer Res"},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01724-5"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02864"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-203800"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11303"},{"key":"e_1_3_6_120_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-162621"},{"key":"e_1_3_6_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.06.006"},{"key":"e_1_3_6_122_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-179369"},{"key":"e_1_3_6_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0181-2"},{"key":"e_1_3_6_124_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.637420"},{"key":"e_1_3_6_125_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1240678"},{"key":"e_1_3_6_126_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024373"},{"key":"e_1_3_6_127_1","unstructured":"Mascarenhas JAH Ali H Yacoub AR et al. INCA33989 is a novel first in class mutant calreticulin-specific monoclonal antibody that demonstrates safety and efficacy in patients with essential thrombocythemia (ET). EHA Library 4173810; LB4002."},{"key":"e_1_3_6_128_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173430"},{"key":"e_1_3_6_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17469"},{"key":"e_1_3_6_130_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-608315"},{"key":"e_1_3_6_131_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.4886"},{"key":"e_1_3_6_132_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-12-890889"},{"key":"e_1_3_6_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00305-8"},{"key":"e_1_3_6_134_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008158"},{"key":"e_1_3_6_135_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2784-x"},{"key":"e_1_3_6_136_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2485"},{"key":"e_1_3_6_137_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.3.586"},{"key":"e_1_3_6_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.11.001"},{"key":"e_1_3_6_139_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.031831"},{"key":"e_1_3_6_140_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000001"},{"key":"e_1_3_6_141_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13198"},{"key":"e_1_3_6_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.02.016"},{"key":"e_1_3_6_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02717-8"},{"key":"e_1_3_6_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.01.017"},{"key":"e_1_3_6_145_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.06135"},{"key":"e_1_3_6_146_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2435-7"},{"key":"e_1_3_6_147_1","doi-asserted-by":"publisher","DOI":"10.1159\/000097463"},{"key":"e_1_3_6_148_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12846"},{"issue":"8","key":"e_1_3_6_149_1","first-page":"1027","article-title":"Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study","volume":"91","author":"Abgrall JF","year":"2006","unstructured":"Abgrall JF, Guibaud I, Bastie JN, et al. Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study. Haematologica. 2006;91(8):1027\u20131032.","journal-title":"Haematologica"},{"key":"e_1_3_6_150_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-287417"},{"key":"e_1_3_6_151_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.299"},{"key":"e_1_3_6_152_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-004572"},{"key":"e_1_3_6_153_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.6548"},{"key":"e_1_3_6_154_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03443.x"},{"key":"e_1_3_6_155_1","doi-asserted-by":"publisher","DOI":"10.4065\/79.7.883"},{"key":"e_1_3_6_156_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2928"},{"key":"e_1_3_6_157_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.2"},{"key":"e_1_3_6_158_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.8711"},{"key":"e_1_3_6_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(00)00488-4"},{"key":"e_1_3_6_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00203-5"},{"key":"e_1_3_6_161_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012939"},{"key":"e_1_3_6_162_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140167"},{"key":"e_1_3_6_163_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-201729"},{"key":"e_1_3_6_164_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-740092"},{"key":"e_1_3_6_165_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002662"},{"key":"e_1_3_6_166_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181055"},{"key":"e_1_3_6_167_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00104"},{"key":"e_1_3_6_168_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2432"},{"key":"e_1_3_6_169_1","unstructured":"Tefferi AAM Stubbs M Pusey M et al. DISC-0974 (an anti-hemojuvelin antibody) in non-transfusion-dependent patients with myelofibrosis: laboratory correlates of major anemia response. Abstract PS1845 EHA 2025 Congress. Milan (IT); 2025 Jun 12\u201315."},{"key":"e_1_3_6_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.01.016"},{"key":"e_1_3_6_171_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-064626"},{"key":"e_1_3_6_172_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06807.x"},{"key":"e_1_3_6_173_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.769537"},{"key":"e_1_3_6_174_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13005"},{"key":"e_1_3_6_175_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14601"},{"key":"e_1_3_6_176_1","doi-asserted-by":"publisher","DOI":"10.1159\/000512929"},{"key":"e_1_3_6_177_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106456"},{"key":"e_1_3_6_178_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26381"},{"key":"e_1_3_6_179_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003934"},{"key":"e_1_3_6_180_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16709"},{"key":"e_1_3_6_181_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001528"},{"key":"e_1_3_6_182_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19027"},{"key":"e_1_3_6_183_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002119"},{"key":"e_1_3_6_184_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0778-0"},{"key":"e_1_3_6_185_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012880"},{"key":"e_1_3_6_186_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761999"},{"key":"e_1_3_6_187_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.0240"},{"key":"e_1_3_6_188_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133331"},{"key":"e_1_3_6_189_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34722"},{"key":"e_1_3_6_190_1","unstructured":"Palandri FO O\u2019Connell C Vachhani P. Survival impact and kinetics of hemoglobin improvement with momelotinib in patients with myelofibrosis and moderate to severe anemia: post hoc analyses of simplify-1 and momentum. EHA Library Palandri F; [2025 Jun 13]; 4160235; PF828."},{"key":"e_1_3_6_191_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023719"},{"key":"e_1_3_6_192_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024220"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2025.2604532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:59:13Z","timestamp":1772726353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2025.2604532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":190,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/17474086.2025.2604532"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2025.2604532","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}